Adam Szczuciński

Statistics

Publications

Citations

110

H-Index

Active since

2004

Affiliations

Polish Academy of Sciences(Current)

Poznan University of Medical Sciences

Adam Szczuciński is an author at Polish Academy of Sciences specializing in relapsing-remitting multiple sclerosis treatment, life sciences, and neuroinflammation in multiple sclerosis.

Publications per year

2004–2010

Publications

CCL5, CXCL10 and CXCL11 Chemokines in Patients with Active and Stable Relapsing-Remitting Multiple Sclerosis

Adam Szczuciński, Jacek Losy · NeuroImmunoModulation · 2010 · 36 citations

Life Sciences, Immunology, Neurology +17

Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing−remitting multiple sclerosis patients

Alicja Kalinowska, Adam Szczuciński, Mikołaj A. Pawlak et al. · Journal of the Neurological Sciences · 2010 · 31 citations

Life Sciences, Immunology, Pathobiology +11

Effect of methylprednisolone treatment on expression of sPECAM-1 and CXCL10 chemokine in serum of MS patients.

G Michałowska-Wender, Jacek Losy, Adam Szczuciński et al. · PubMed · 2007 · 15 citations

Life Sciences, Immunology, Pharmacology +13

CXCL11 (Interferon-Inducible T-Cell Alpha Chemoattractant) and Interleukin-18 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Methylprednisolone

Adam Szczuciński, Alicja Kalinowska, Jacek Losy · European Neurology · 2007 · 14 citations

Life Sciences, Immunology, Pharmacology +17

Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosis.

Adam Szczuciński, Jacek Losy · PubMed · 2004 · 14 citations

Life Sciences, Immunology, Neurology +17

1–5 of 5